Research Article

Comparison of cardiotoxicity of levobupivacaine and bupivacaine with the brain natriuretic peptide

Volume: 40 Number: 2 June 28, 2018
EN

Comparison of cardiotoxicity of levobupivacaine and bupivacaine with the brain natriuretic peptide

Abstract

Introduction: Local anesthetics are also considered to be potentially toxic to the cardiovascular system since they act on ion channels in nerve cell membranes as well as in other tissues that can be stimulated.

Aim: In this study we aimed to compare cardiotoxicity levels of both drugs with brain natriuretic peptide (BNP) protein level in patients undergoing combined spinal epidural anesthesia and postoperative analgesia when given bupivacaine and levobupivacaine at equipotent doses.

Materyal and Method: In this prospective, randomized, double-blind study a total of 30 patients, aged 25-70 years, who were included in the American Society of Anesthesiologists (ASA) I-III risk class and underwent total knee arthroplasty surgery, were included in the study. Patients were randomized as Group I (n = 15) Levobupivacaine and Group II (n = 15) bupivacaine and combined spinal-epidural anesthesia was administered. The operation follow-up of patients were evaluated with the systolic arterial pressure (SAB), the diastolic arterial pressure (DAB), the mean arterial pressure (MAP) and the heart rate (HR), and postoperative follow-up with SAB, DAB, KH, visual analogue scale (VAS) values were monitored at zero minute, 1st, 6th, 12th and 24th hour. BNP levels were measured at 5th minute after spinal anesthesia, sensory block at thoracal level 10 and post-operative 24th hour.

Results: A statistically significant difference was found in the VAS values ​​measured at postoperative 12th hour and 24th hour in favor of levobupivacaine group (p <0.05). In the comparison of BNP levels between the groups, there was no statistically significant difference between the two groups at all measurement times (p> 0.05).

Conclusion: Similar results were obtained in intraoperative and postoperative BNP levels when using levobupivacaine and bupivacaine in equal doses for both spinal anesthesia and epidural analgesia.

Keywords

References

  1. 1. Erdine S, Özyalçın SN, Raj PP, et al. Rejyonal Anestezi. İstanbul: Nobel Tıp Kitabevleri;2005; p.185-91.
  2. 2. Rawal N, Holmstrom B, Crowhurst JA, Van Zundert A. The combined spinal- epidural technique anesthesiology. Anesthesiol Clin North America. 2000; 18: 267-95.
  3. 3. Collins JV. Principles of Anaesthesiology. Third Edition. Philadelphia Lea and Febiger; 1993; p.1445-97.
  4. 4. Chester C, Bleckner LL. Anaesthetic agents for advanced regional anaesthesia. Drug. 2005; 65: 745-59.
  5. 5. Kayhan Z. Klinik Anestezi. 2. Baskı. İstanbul Logos Yayıncılık; 2004; p. 503-23.
  6. 6. Bader AM, Tsen LC, Camann WR, Nephew E, Datta S. CIinical effects and maternal and fetal plasma concentrations of %0,5 epidural levobupivacaine versus bupivacaine for cesarean delivery. Anesthesiology. 1999; 90: 1596-601.
  7. 7. Casati A, Moizo E, Marchetti C, Vinciguerra F. A prospective, randomized, double-blind comparison of unilateral spinal anesthesia with hyperbaric bupivacaine, ropivacaine, or levobupivacaine for inguinal herniorrhaphy. Anesth Analg. 2004; 99:1387-92.
  8. 8. Suttner SW, Boldt J. Natriuretic peptide system: physiology and clinical utility. Curr Opin Crit Care. 2004;10: 336–41.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Publication Date

June 28, 2018

Submission Date

January 22, 2018

Acceptance Date

June 21, 2018

Published in Issue

Year 2018 Volume: 40 Number: 2

AMA
1.Ökmen K, Göğüş N. Comparison of cardiotoxicity of levobupivacaine and bupivacaine with the brain natriuretic peptide. CMJ. 2018;40(2):184-193. doi:10.7197/223.v40i37154.382503